Utility of ctDNA in CAR-T and bispecific therapy with Dr. Brian Sworder, MD General 3 Mins Read61 Introduction During the CAR-T & Bispecifics Conference, Dr. Brian Sworder, MD, from UCI Irvine, shared compelling insights on the utility…
Nitin Jain, MD Challenging case involving advanced B-cell lymphoblastic leukemia (BLL) from the CAR-T and Bispecifics Conference [2024] Chronic Lymphocytic Leukemia 3 Mins Read106 Introduction During the recent CAR-T & Bispecifics conference, Dr. Nitin Jain, MD, from MD Anderson Cancer Center in Houston, Texas,…
Bispecific Antibodies: Revolution in Oncology Multiple Myeloma 12 Mins Read1 KEY TAKEAWAYS Bispecific antibodies, such as talquetamab, represent a transformative shift in cancer treatment, offering the potential to target two…
